Tool Could Spare Tens of Thousands Prostate Care
Tool Could Spare Tens of Thousands Prostate Care
Tool Could Spare Tens of Thousands Prostate Care
Key points
اہم نکات
मुख्य बातें
- A new computer tool could spare tens of thousands of men from needless prostate cancer biopsies and treatment by predicting which cancers will turn deadly and which will not.
- The £1.4 million Reimagine project, funded by Prostate Cancer UK, will use data from more than 1,000 patients — samples, MRI scans and blood and urine tests — to build a digital model of how the disease develops.
- Current tests cannot reliably predict how a man’s cancer will progress, leaving tens of thousands each year facing side effects such as incontinence from unneeded treatment while aggressive cancers are sometimes missed.
- A new computer tool could spare tens of thousands of men from needless prostate cancer biopsies and treatment by predicting which cancers will turn deadly and which will not.
- The £1.4 million Reimagine project, funded by Prostate Cancer UK, will use data from more than 1,000 patients — samples, MRI scans and blood and urine tests — to build a digital model of how the disease develops.
- Current tests cannot reliably predict how a man’s cancer will progress, leaving tens of thousands each year facing side effects such as incontinence from unneeded treatment while aggressive cancers are sometimes missed.
- A new computer tool could spare tens of thousands of men from needless prostate cancer biopsies and treatment by predicting which cancers will turn deadly and which will not.
- The £1.4 million Reimagine project, funded by Prostate Cancer UK, will use data from more than 1,000 patients — samples, MRI scans and blood and urine tests — to build a digital model of how the disease develops.
- Current tests cannot reliably predict how a man’s cancer will progress, leaving tens of thousands each year facing side effects such as incontinence from unneeded treatment while aggressive cancers are sometimes missed.
A new computer tool could spare tens of thousands of men from needless prostate cancer biopsies and treatment by predicting which cancers will turn deadly and which will not. The £1.4 million Reimagine project, funded by Prostate Cancer UK, will use data from more than 1,000 patients — samples, MRI scans and blood and urine tests — to build a digital model of how the disease develops. Current tests cannot reliably predict how a man’s cancer will progress, leaving tens of thousands each year facing side effects such as incontinence from unneeded treatment while aggressive cancers are sometimes missed. The trial, led by King’s College London with University College London and Imperial College London, starts on 10 December.
A new computer tool could spare tens of thousands of men from needless prostate cancer biopsies and treatment by predicting which cancers will turn deadly and which will not. The £1.4 million Reimagine project, funded by Prostate Cancer UK, will use data from more than 1,000 patients — samples, MRI scans and blood and urine tests — to build a digital model of how the disease develops. Current tests cannot reliably predict how a man’s cancer will progress, leaving tens of thousands each year facing side effects such as incontinence from unneeded treatment while aggressive cancers are sometimes missed. The trial, led by King’s College London with University College London and Imperial College London, starts on 10 December.
A new computer tool could spare tens of thousands of men from needless prostate cancer biopsies and treatment by predicting which cancers will turn deadly and which will not. The £1.4 million Reimagine project, funded by Prostate Cancer UK, will use data from more than 1,000 patients — samples, MRI scans and blood and urine tests — to build a digital model of how the disease develops. Current tests cannot reliably predict how a man’s cancer will progress, leaving tens of thousands each year facing side effects such as incontinence from unneeded treatment while aggressive cancers are sometimes missed. The trial, led by King’s College London with University College London and Imperial College London, starts on 10 December.
Most read
سب سے زیادہ پڑھی گئی
सबसे ज़्यादा पढ़ी गई
- Loading...
Get news in your inbox
خبریں اپنے ان باکس میں حاصل کریں
खबरें अपने इनबॉक्स में पाएं
One email when new stories are published. No spam, unsubscribe anytime.
نئی خبریں شائع ہونے پر ایک ای میل۔ کوئی سپیم نہیں، کسی بھی وقت ان سبسکرائب کریں۔
नई खबरें प्रकाशित होने पर एक ईमेल। कोई स्पैम नहीं, कभी भी अनसब्सक्राइब करें।